These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38962872)

  • 1. Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass.
    Gebreyesus MS; Dresner A; Wiesner L; Coetzee E; Verschuuren T; Wasmann R; Denti P
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; ():. PubMed ID: 38962872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass.
    Poltak J; Connors C; Wungwattana M; Nicolau D; Mercuro NJ; Liu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2942-2947. PubMed ID: 35227575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation.
    Šantavý P; Šíma M; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Urbánek K
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
    Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
    Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
    Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
    J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.
    Lanoiselée J; Zufferey PJ; Hodin S; Tamisier N; Gergelé L; Palao JC; Campisi S; Molliex S; Morel J; Delavenne X; Ollier E
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial.
    Naik BI; Roger C; Ikeda K; Todorovic MS; Wallis SC; Lipman J; Roberts JA
    Br J Anaesth; 2017 Jun; 118(6):876-882. PubMed ID: 28505360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.
    Yang QJ; Jerath A; Bies RR; Wąsowicz M; Pang KS
    Biopharm Drug Dispos; 2015 Jul; 36(5):294-307. PubMed ID: 25704361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight.
    Chung EK; Cheatham SC; Healy DP; Stock AH; Utley S; Campion M; Murrey T; Gesenhues AM; Jeffery J; Kays MB
    Int J Antimicrob Agents; 2023 Apr; 61(4):106751. PubMed ID: 36758780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
    Salvador E; Oualha M; Bille E; Beranger A; Moulin F; Benaboud S; Boujaafar S; Gana I; Urien S; Zheng Y; Toubiana J; Briand C; Bustarret O; Geslain G; Renolleau S; Treluyer JM; Hirt D
    Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.
    Alli A; Paruk F; Roger C; Lipman J; Calleemalay D; Wallis SC; Scribante J; Richards GA; Roberts JA
    PLoS One; 2023; 18(9):e0291425. PubMed ID: 37729151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
    Lapmahapaisan S; Maisat W; Tantiwongkosri K; Jutasompakorn P; Sisan W
    Ann Card Anaesth; 2021; 24(2):149-154. PubMed ID: 33884969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass.
    Tae YM; Kwak JG; Kim BH; Jang IJ; Kim WH
    J Clin Pharmacol; 2011 Aug; 51(8):1163-76. PubMed ID: 20926755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery.
    Khaowroongrueng V; Son KH; Lee SM; Lee J; Park CG; Lee SI; Shin D; Shin KH
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; ():. PubMed ID: 39039947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.
    Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA
    Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.